Log In
Print
BCIQ
Print
Print this Print this
 

GVAX Pancreas cancer vaccine

Also known as: BioSante vaccine for pancreatic cancer

  Manage Alerts
Collapse Summary General Information
Company Aduro Biotech Inc.
DescriptionAllogeneic cancer vaccine engineered to secrete GM-CSF
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationPancreatic cancer
Indication DetailsTreat advanced pancreatic cancer; Treat metastatic pancreatic cancer; Treat operable pancreatic cancer; Treat pancreatic cancer
Regulatory Designation

U.S. - Breakthrough Therapy (Treat pancreatic cancer);
U.S. - Orphan Drug (Treat pancreatic cancer)

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$1.0M

$1.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today